Cargando…
Chondrocytic and pharmacokinetic properties of Phlpp inhibitors
OBJECTIVE: The pleckstrin homology domain leucine-rich repeat protein phosphatases (Phlpp1/2) were recently identified as potential therapeutic targets for cartilage regeneration in osteoarthritic joints. Phlpp inhibitors NSC 117079 and NSC 45586 increase chondrocyte proliferation and matrix product...
Autores principales: | Taylor, E.L., Weaver, S.R., Zars, E.L., Turner, C.A., Buhrow, S.A., Reid, J.M., Bradley, E.W., Westendorf, J.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718091/ https://www.ncbi.nlm.nih.gov/pubmed/36474816 http://dx.doi.org/10.1016/j.ocarto.2021.100190 |
Ejemplares similares
-
Detection of PHLPP1α/β in Human and Mouse Brain by Different Anti-PHLPP1 Antibodies
por: Jackson, Travis C., et al.
Publicado: (2015) -
Emerging roles of PHLPP phosphatases in metabolism
por: Cha, Jong-Ho, et al.
Publicado: (2021) -
Aberrant Expression of PHLPP1 and PHLPP2 Correlates with Poor Prognosis in Patients with Hypopharyngeal Squamous Cell Carcinoma
por: Zhou, Jieyu, et al.
Publicado: (2015) -
Phlpp1 is associated with human intervertebral disc degeneration and its deficiency promotes healing after needle puncture injury in mice
por: Zhang, Changli, et al.
Publicado: (2019) -
PHLPP1 regulates CFTR activity and lumen expansion through AMPK
por: Lobert, Viola H., et al.
Publicado: (2022)